Show simple item record

A case report of bone marrow suppression caused by piperacillin tazobactam

dc.contributor.authorEkmekci, Ahmet
dc.contributor.authorTufan, Fatih
dc.contributor.authorDemirturk, Mustafa
dc.contributor.authorCagatay, Arif Atahan
dc.contributor.authorYakar, Fatih
dc.date.accessioned2021-03-05T09:52:49Z
dc.date.available2021-03-05T09:52:49Z
dc.date.issued2008
dc.identifier.citationEkmekci A., Yakar F., Tufan F., Demirturk M., Cagatay A. A. , "A case report of bone marrow suppression caused by piperacillin tazobactam", NOBEL MEDICUS, cilt.4, ss.28-30, 2008
dc.identifier.issn1305-2381
dc.identifier.othervv_1032021
dc.identifier.otherav_a01543a4-823a-4bd7-a828-d59b7007d1fe
dc.identifier.urihttp://hdl.handle.net/20.500.12627/107391
dc.description.abstractPiperacillin/tazobactam (PT) is a commonly prescribed antibiotic and is generally considered safe. During treatment with piperacillin/tazobactam bone marrow suppression can rarely be seen as a serious adverse effect. We report here a case of PT induced bone marrow suppression. A 58 year old man was being treated with PT for empyema. After 20 days of treatment, he developed neutropenia and thrombocytopenia.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleA case report of bone marrow suppression caused by piperacillin tazobactam
dc.typeMakale
dc.relation.journalNOBEL MEDICUS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume4
dc.identifier.issue1
dc.identifier.startpage28
dc.identifier.endpage30
dc.contributor.firstauthorID67681


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record